seatt##### Listed by clop Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

On December 24, 2024, the ransomware group clop listed seatt##### on its leak site, claiming the organisation as a victim of a ransomware attack in which internal files were exfiltrated. Public reporting identifies the presumed victim as Seattle Genetics. The number of people affected remains unknown, and further specifics about the incident have not been disclosed. The listing itself constitutes a claim by the group rather than independently confirmed detail.

For individuals and organisations connected to seatt#####, the development raises practical questions about what information may have left the organisation’s systems and what steps can reduce personal risk while fuller details are still limited.

What happened

According to the available record, seatt##### was listed by the clop ransomware group on December 24, 2024. The group’s announcement asserts that internal files were exfiltrated as part of a ransomware attack. The reported summary notes that clop claims to hold data from many companies that use Cleo software and states that its teams are reaching out and offering a “special secret chat.” No confirmed timeline of the intrusion, no verified volume of data taken, and no independent confirmation of the listing have been made public. The number of people affected is listed as unknown. Public detail on the precise method of access and the full scope of the incident therefore remains limited.

The group behind it: clop

Clop (also styled Cl0p) is a well-documented ransomware operation that has operated for several years using a double-extortion model: encrypting systems while also stealing data and threatening to publish it if a ransom is not paid. The group has repeatedly targeted organisations through vulnerabilities in widely used file-transfer and managed-file-transfer products. In recent campaigns it has publicly claimed victims that use Cleo software, consistent with the language in its announcement regarding seatt#####. Clop typically posts victim names on a dedicated leak site and sometimes releases sample files to pressure payment. Its listings are claims; they do not by themselves prove the accuracy or completeness of the data the group says it holds. Prior activity by the group has included high-profile campaigns against multiple sectors, often exploiting unpatched software rather than relying solely on phishing or other initial-access methods.

About seatt#####

Seatt##### is identified in the reporting as the presumed name Seattle Genetics, a biotechnology company focused on developing antibody-drug conjugates and other therapies, primarily in oncology. Organisations of this type typically maintain research data, clinical-trial information, intellectual property, employee records, vendor contracts, and communications with partners and regulators. Because such companies sit at the intersection of healthcare, research, and commercial pharmaceutical development, a breach can affect not only internal operations but also patients, trial participants, employees, and business partners who rely on the confidentiality of sensitive material. The listing of seatt##### by a ransomware group therefore carries sector-wide implications even while the precise contents of any stolen data remain unconfirmed.

What was likely exposed

The only data type named in the available facts is “internal files exfiltrated in ransomware attack.” No further breakdown—such as whether the files included personal data, clinical records, financial documents, or source code—has been disclosed. The number of people affected is unknown. Organisations in the biotechnology and pharmaceutical sector commonly hold employee personal information, research datasets, intellectual property, partner agreements, and sometimes patient or trial-related data. Any of these categories could be among the internal files claimed by clop, yet the exact contents remain unconfirmed. Readers should treat assertions about specific data types as unverified until independent reporting or official statements provide clearer inventories.

Why it matters

For people whose information may have been among the internal files, the primary risks are identity theft, targeted phishing, and misuse of personal or professional details. Even limited employee or contractor data can enable social-engineering attacks that impersonate colleagues or vendors. For the organisation itself, exposure of internal files can disrupt research continuity, create regulatory and contractual obligations, and damage trust with partners and patients. Because the scale of the incident and the precise data involved are still unknown, the practical impact cannot yet be quantified. The listing does, however, place seatt##### among a series of organisations that clop has claimed after campaigns involving Cleo software, underscoring the broader pattern of supply-chain and third-party software risk that many enterprises face.

Were you affected?

If you have a current or former relationship with seatt#####—as an employee, contractor, clinical-trial participant, or partner—monitor financial and email accounts for unusual activity and be cautious of unsolicited messages that reference the organisation or request credentials. Change passwords on any accounts that reused credentials associated with work systems, and enable multi-factor authentication where available. Because the full extent of exposed data is unconfirmed, treat any unexpected contact claiming to relate to this incident with skepticism. Readers can also run a free exposure scan of their email address to check whether that address has already appeared in known breach datasets; such a scan provides one additional data point while official notifications, if any, are still pending.

AICompiled with AI assistance from public sources and published under our editorial standards.